IN8bio Inc.
INAB | NASDAQ
$1.12
+$0.06 (+5.66%)
Sep 22, 2026, 12:31 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -0.53 | -13.54 | -41.40 | -50.96 | -168.85 | -566.04 |
PEG Ratio | 0 | 0.31 | 1.56 | -0.69 | -3.58 | -5.88 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 0.37 | 0.95 | 1.65 | 2.13 | 2.16 | 10.56 |
P/FCF Ratio | -0.81 | -0.57 | -1.72 | -1.74 | -5.97 | -27.13 |
P/OCF Ratio | -0.81 | -0.57 | -1.77 | -2.01 | -6.10 | -27.13 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.10 | 0.35 | 0.20 | 0.26 | 0.06 | 0.01 |
Quick Ratio | 8.82 | 4.08 | 4.57 | 3.82 | 17.28 | 7.05 |
Current Ratio | 8.82 | 4.08 | 4.57 | 3.82 | 17.28 | 7.05 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -70.54% | -210.23% | -120.33% | -125.47% | -38.38% | -46.71% |
Return on Assets | -60.22% | -145.33% | -89.02% | -86.33% | -34.70% | -40.92% |
Return on Invested Capital | -65.46% | -156.02% | -101.70% | -99.70% | -36.10% | -46.22% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove INAB